Xu Youzheng, Xu Yixin, Wang Chun, Xia Baoguo, Mu Qingling, Luan Shaohong, Fan Jun
Department of Gynecology, Qingdao Municipal Hospital, Qingdao, China.
Department of Neurology, Qingdao Municipal Hospital, Qingdao, China.
PeerJ. 2021 May 4;9:e11375. doi: 10.7717/peerj.11375. eCollection 2021.
Ovarian cancer is one of the leading causes of female deaths worldwide. Ovarian serous cystadenocarcinoma occupies about 90% of it. Effective and accurate biomarkers for diagnosis, outcome prediction and personalized treatment are needed urgently.
Gene expression profile for OSC patients was obtained from the TCGA database. The ESTIMATE algorithm was used to calculate immune scores and stromal scores of expression data of ovarian serous cystadenocarcinoma samples. Survival results between high and low groups of immune and stromal score were compared and differentially expressed genes (DEGs) were screened out by limma package. The Gene Ontology (GO), the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and the protein-protein interaction (PPI) network analysis were performed with the g:Profiler database, the Cytoscape and Search Tool for the Retrieval of Interacting Genes (STRING-DB). Survival results between high and low immune and stromal score groups were compared. Kaplan-Meier plots based on TCGA follow up information were generated to evaluate patients' overall survival.
Eighty-six upregulated DEGs and one downregulated DEG were identified. Three modules, which included 49 nodes were chosen as important networks. Seven DEGs () were considered to be correlated with poor overall survival.
Seven DEGs (, , , , , , ) were correlated with poor overall survival in our study. This new set of genes can become strong predictor of survival, individually or combined. Further investigation of these genes is needed to validate the conclusion to provide novel understanding of tumor microenvironment with ovarian serous cystadenocarcinoma prognosis and treatment.
卵巢癌是全球女性死亡的主要原因之一。卵巢浆液性囊腺癌约占其中的90%。迫切需要有效且准确的生物标志物用于诊断、预后预测和个性化治疗。
从TCGA数据库获取卵巢浆液性囊腺癌(OSC)患者的基因表达谱。使用ESTIMATE算法计算卵巢浆液性囊腺癌样本表达数据的免疫评分和基质评分。比较免疫和基质评分高、低分组之间的生存结果,并通过limma软件包筛选差异表达基因(DEGs)。使用g:Profiler数据库、Cytoscape和搜索互作基因工具(STRING-DB)进行基因本体论(GO)、京都基因与基因组百科全书(KEGG)通路富集分析以及蛋白质-蛋白质相互作用(PPI)网络分析。比较免疫和基质评分高、低分组之间的生存结果。根据TCGA随访信息生成Kaplan-Meier曲线以评估患者的总生存期。
鉴定出86个上调的DEGs和1个下调的DEG。选择了包含49个节点的三个模块作为重要网络。7个DEGs(……)被认为与总生存期较差相关。
在我们的研究中,7个DEGs(……)与总生存期较差相关。这一组新基因单独或联合起来都可成为强有力的生存预测指标。需要对这些基因进行进一步研究以验证该结论,从而为卵巢浆液性囊腺癌的预后和治疗提供对肿瘤微环境的新认识。